Independent research Source-backed profiles No paid rankings
Peptide Provider Direct
M
Unclaimed8 services cataloged

Mudita

Helena, MT · Telehealth available

Visit provider website ↗

Provider overview

About Mudita

Mudita is a Helena practice led by Morgan Pedersen, FNP-C. Official pages state that Pedersen is licensed in Montana, Iowa, Colorado, Utah, and Florida and offers telehealth in licensed states. The site advertises named peptide protocols, compounded semaglutide and tirzepatide programs, hormone optimization, and laboratory-guided follow-up. These are provider-reported offerings; the profile does not infer approval, pharmacy identity, formulation, availability, safety, or efficacy.

At a glance

Market role
Direct patient-care provider
Care model
Telehealth and In person
Coverage
5 listed jurisdictions
Pharmacy pathway
Not publicly established

503A and 503B labels describe statutory compounding pathways or public relationships. They do not mean a compounded drug is FDA-approved or that FDA endorses a facility.

Service catalog

Programs and services

Provider-advertised services, grouped for quick scanning with all details visible.

8 cataloged
01

Peptide-related care

3

Sermorelin and CJC-1295/ipamorelin

These growth-hormone-axis protocols are named by the provider; approval, formulation, and availability require direct confirmation.

Provider source ↗

BPC-157 and Thymosin Alpha-1

The clinic advertises these recovery and immune-related compounds without establishing regulatory status for promoted uses.

Provider source ↗

AOD-9604 and GHK-Cu

These names appear in the official peptide catalog and are recorded without adopting outcome claims.

Provider source ↗
02

Longevity programs

1

NAD+ services

NAD+ is listed among the practice's wellness offerings; route and eligibility require direct confirmation.

Provider source ↗
03

GLP-1 and metabolic programs

2

Compounded semaglutide program

The provider advertises a medically monitored compounded semaglutide option without naming the dispensing pharmacy.

Provider source ↗

Compounded tirzepatide program

The provider advertises a compounded tirzepatide option; availability and formulation require current clinical confirmation.

Provider source ↗
04

Hormone health

1

Hormone optimization

Hormone evaluation and personalized treatment are described for eligible patients.

Provider source ↗
05

Laboratory services

1

Laboratory review and monitoring

The practice describes laboratory assessment and ongoing review within metabolic and hormone programs.

Provider source ↗
Important: Inclusion does not establish availability for every patient or state, regulatory status, clinical appropriateness, safety, or effectiveness.

Coverage and research

Explore this provider’s markets

Review every state page this provider advertises serving, then use the related guides to evaluate services and claims.

Continue comparing

Related provider profiles

Evidence

Sources reviewed

These links support the public facts recorded here. Provider-published information is not an independent endorsement.